Showing results (591-600 of 706) with videos related to
Sort By:
Pageof 71
Bone Marrow Transplantation|July 1, 2014
Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioningM Shanavas, H A Messner, E G Atenafu, et al.Bone Marrow Transplantation|March 4, 2014
Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk modelsD Kim, H-H Won, S Su, et al.Retrovirology|July 11, 2006
Involvement of HTLV-I Tax and CREB in aneuploidy: a bioinformatics approachCynthia de la Fuente, Madhur V Gupta, Zachary Klase, et al.Blood Cancer Journal|May 28, 2013
The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogeneticsJ How, J Sykes, M D Minden, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?N Timilshina, H Breunis, J M Brandwein, et al.Indian Pediatrics|May 1, 1993
Breastfeeding and childhood cancerG P Mathur, N Gupta, S Mathur, et al.Bone Marrow Transplantation|March 17, 2015
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHDN Alam, W Xu, E G Atenafu, et al.South Asian Journal of Cancer|May 4, 2018
Practical consensus recommendations regarding role of postmastectomy radiation therapyD Singh, G Saini, R Koul, et al.Journal of Applied Microbiology|August 29, 2018
Rapid visual isothermal nucleic acid-based detection assay of Brucella species by polymerase spiral reactionA Das, B Kumar, S Chakravarti, et al.Leukemia|March 22, 2013
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaS V Rajkumar, V Gupta, R Fonseca, et al.Pageof 71